Picture of Divi's Laboratories logo

DIVISLAB — Divi's Laboratories News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

India's Divi's Labs down on Q2 profit miss

** Shares of Divi's Laboratories  DIVI.NS  fall as much as
3% to 3,401.1 rupees, steepest intraday fall since Sept. 28
    ** The pharmaceutical co reported on Monday its consolidated
profit fell 29.4% to 3.48 bln rupees ($41.81 million) and missed
analysts' estimate of 4.41 billion rupees, as per LSEG data
    ** Co's margin dragged by higher expenses despite easing
price pressures in U.S. markets
    ** DIVI trading below its 50-day and 100-day simple moving
averages since mid October
    ** Mean rating of 21 analysts covering the stock is "sell";
median PT is 3,030 rupees - LSEG data
    ** Stock currently down 1.6% trimming YTD gains to 1.1%



($1 = 83.2425 Indian rupees)

 (Reporting by Ashna Teresa Britto in Bengaluru)
 ((AshnaTeresa.Britto@thomsonreuters.com ; ( +91 8078332441))

Recent news on Divi's Laboratories

See all news